Rearrangement of Imidazolidine to Piperazine Rings in the Presence of DyIII
Author:
Corredoira-Vázquez JulioORCID,
Oreiro-Martínez Paula,
Deibe Ana M. GarcíaORCID,
Sanmartín-Matalobos JesúsORCID,
Fondo MatildeORCID
Reference12 articles.
1. Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals;Vitaku;J. Med. Chem.,2014
2. Sochacka-Ćwikła, A., Mączyński, M., and Regiec, A. (2022). FDA-approved small molecule compounds as drugs for solid cancers from early 2011 to the end of 2021. Molecules, 27.
3. Predetermined ferromagnetic coupling via strict control of M-O-M angles;Fondo;Inorg. Chem.,2016
4. Recent advances in the synthesis of piperazine based ligands and metal complexes and their applications;Kant;Dalton Trans.,2021
5. Imidazolidine ring cleavage upon complexation with first-row transition metals;Cheaib;Eur. J. Inorg. Chem.,2017